All Stories

  1. Identification of Potential Prophylactic Medical Countermeasures Against Acute Radiation Syndrome (ARS)
  2. Metabolic control of luteinizing hormone-responsive ovarian steroidogenesis
  3. A reproducibility crisis for clinical metabolomics studies
  4. Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Applications for Metabolomics
  5. Simulated LC–MS Data Set for Assessing the Metabolomics Data Processing Pipeline Implemented into MVAPACK
  6. Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids
  7. Best practices in NMR metabolomics: Current state
  8. Evaluating Protocols for Reproducible Targeted Metabolomics by NMR
  9. Frontiers in NMR metabolomics
  10. Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant—Antioxidant Balance
  11. Multiplatform untargeted metabolomics
  12. The reversible low‐temperature instability of human DJ‐1 oxidative states
  13. Multiomics Approach Captures Hepatic Metabolic Network Altered by Chronic Ethanol Administration
  14. Chemical shift variations in common metabolites
  15. Leveraging the HMBC to Facilitate Metabolite Identification
  16. Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue
  17. Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies
  18. Meta-Analysis Reveals Both the Promises and the Challenges of Clinical Metabolomics
  19. NMR and Metabolomics—A Roadmap for the Future
  20. Human Serum Alters the Metabolism and Antibiotic Susceptibility of Staphylococcus aureus
  21. Gadolinium-Based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-Based Metabolomics
  22. Closing the gap between in vivo and in vitro omics: using QA/QC to strengthen ex vivo NMR metabolomics
  23. DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma
  24. Quantitative NMR-Based Biomedical Metabolomics: Current Status and Applications
  25. DNAJA1 dysregulates metabolism promoting an anti-apoptotic phenotype in pancreatic ductal adenocarcinoma
  26. Phosphorus NMR and Its Application to Metabolomics
  27. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics
  28. Evaluation of Multivariate Classification Models for Analyzing NMR Metabolomics Data
  29. Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity
  30. Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth
  31. O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3
  32. Functional Evolution of Proteins
  33. Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection
  34. Insights into gemcitabine resistance and the potential for therapeutic monitoring
  35. Combining Mass Spectrometry and NMR Improves Metabolite Detection and Annotation
  36. Comparing normalization methods and the impact of noise
  37. Expanding the Coverage of the Metabolome with Nitrogen-Based NMR
  38. 15 N CEST data and traditional model-free analysis capture fast internal dynamics of DJ-1
  39. Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility
  40. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
  41. Nanoformulated Copper/Zinc Superoxide Dismutase Exerts Differential Effects on Glucose versus Lipid Homeostasis Depending on the Diet Composition Possibly via Altered AMPK Signaling
  42. New frontiers in metabolomics: from measurement to insight
  43. Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
  44. Assessment of Metabolic Changes in Mycobacterium smegmatis Wild-Type and alr Mutant Strains: Evidence of a New Pathway of d-Alanine Biosynthesis
  45. Amino Acid Catabolism in Staphylococcus aureus and the Function of Carbon Catabolite Repression
  46. Identification of a Ligand-Binding Site on the Staphylococcus aureus DnaG Primase C-Terminal Domain
  47. PCA as a Practical Indicator of OPLS-DA Model Reliability
  48. Deterministic multidimensional nonuniform gap sampling
  49. Staphylococcus aureus Metabolic Adaptations during the Transition from a Daptomycin Susceptibility Phenotype to a Daptomycin Nonsusceptibility Phenotype
  50. Meet Our Editor
  51. Preface: “The Whole is Greater Than the Sum of its Parts.” - Aristotle
  52. Faculty of 1000 evaluation for Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
  53. Editorial
  54. Simultaneous phase and scatter correction for NMR datasets
  55. Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes
  56. Growth and Preparation of Staphylococcus epidermidis for NMR Metabolomic Analysis
  57. NMR Metabolomics Analysis of Parkinson's Disease
  58. Faculty of 1000 evaluation for Digestion and depletion of abundant proteins improves proteomic coverage.
  59. Faculty of 1000 evaluation for Metabolite-enabled eradication of bacterial persisters by aminoglycosides.
  60. NMR in Drug Discovery – Introduction
  61. Fragment Screen
  62. SAR by NMR
  63. The Applicability of Molecular Descriptors for Designing an Electrospray Ionization Mass Spectrometry Compatible Library for Drug Discovery
  64. Editorial
  65. Editorial
  66. Multivariate Analysis in Metabolomics
  67. Multivariate Analysis in Metabolomics
  68. Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies
  69. Application of NMR Metabolomics to Search for Human Disease Biomarkers
  70. Analysis of bacterial biofilms using NMR-based metabolomics
  71. Predicting the in Vivo Mechanism of Action for Drug Leads Using NMR Metabolomics
  72. An inexpensive high-throughput nuclear magnetic resonance tube cleaning apparatus
  73. Faculty of 1000 evaluation for Paper spray for direct analysis of complex mixtures using mass spectrometry.
  74. Bacterial protein structures reveal phylum dependent divergence
  75. Faculty of 1000 evaluation for A transient and low-populated protein-folding intermediate at atomic resolution.
  76. Faculty of 1000 evaluation for Enzymatic transition states and dynamic motion in barrier crossing.
  77. Faculty of 1000 evaluation for Molecular docking and ligand specificity in fragment-based inhibitor discovery.
  78. Faculty of 1000 evaluation for Evaluation of virtual screening as a tool for chemical genetic applications.
  79. Faculty of 1000 evaluation for Mapping of ligand-binding cavities in proteins.
  80. Faculty of 1000 evaluation for A hybrid clustering of protein binding sites.
  81. Analysis of metabolomic PCA data using tree diagrams
  82. Faculty of 1000 evaluation for Systems biology: an evolving approach in drug discovery and development.
  83. Advances in nuclear magnetic resonance for drug discovery
  84. Faculty of 1000 evaluation for Structure and energetics of the hydrogen-bonded backbone in protein folding.
  85. NMR metabolomics and drug discovery
  86. Faculty of 1000 evaluation for Metabolite identification via the Madison Metabolomics Consortium Database.
  87. Faculty of 1000 evaluation for Binding similarity network of ligand.
  88. Faculty of 1000 evaluation for Protein dispensability and rate of evolution.
  89. Functional Genomics and NMR Spectroscopy
  90. Faculty of 1000 evaluation for Enzyme function less conserved than anticipated.
  91. Faculty of 1000 evaluation for Intrinsic errors in genome annotation.
  92. Faculty of 1000 evaluation for Discovering high-affinity ligands for proteins: SAR by NMR.
  93. Faculty of 1000 evaluation for Evolutionary rate in the protein interaction network.
  94. APPLICATIONS OF NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY TO ANTICANCER DRUG DISCOVERY
  95. Solution structure of the tumor necrosis factor receptor-1 death domain
  96. Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using nitrogen-15 relaxation measurements
  97. Three-Dimensional Solution Structure of Human Interleukin-4 by Multidimensional Heteronuclear Magnetic Resonance Spectroscopy
  98. Proton, nitrogen-15, carbon-13, carbon-13 monoxide assignments of human interleukin-4 using three-dimensional double- and triple-resonance heteronuclear magnetic resonance spectroscopy
  99. Determination of the secondary structure and folding topology of human interleukin-4 using three-dimensional heteronuclear magnetic resonance spectroscopy
  100. Secondary structure of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase in solution using three-dimensional double and triple resonance heteronuclear magnetic resonance spectroscopy
  101. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams
  102. Three-dimensional triple-resonance NMR of 13C/15N-enriched proteins using constant-time evolution
  103. Two-dimensional proton and phosphorus-31 NMR spectra and restrained molecular dynamics structure of a covalent CPI-CDPI2-oligodeoxyribonucleotide decamer complex
  104. Introduction to NMR and Its Application in Metabolite Structure Determination